ECP-1014 Treatment for Patients With Solid Tumor Cancers
Clinical trial NCT04930354 · UNKNOWN
Trial details
- NCT number
- NCT04930354
- Sponsor
- Euclises Pharmaceuticals, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-01
- Primary completion
- 2023-09-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.